TC BioPharm (Holdings) plc - TCBPY

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2025 · Compare: Q2 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
GAMMA Investing LLC History Closed out 0 0 — — — -230 -100.0% Q3 2025 Oct 02, 2025
RHUMBLINE ADVISERS History Reduced 5 0 — — — -183 -97.34% Q3 2025 Nov 06, 2025